BHVN logo

Biohaven Pharmaceutical Holding (BHVN) Long Term Liabilities

Annual Total Long Term Liabilities

$29.81 M
-$3.18 M-9.63%

31 December 2023

BHVN Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$42.22 M
-$471.00 K-1.10%

30 September 2024

BHVN Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BHVN Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.6%+38.2%
3 y3 years+515.9%+676.9%
5 y5 years-75.1%-85.2%

BHVN Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-9.6%+515.9%-1.1%+676.9%
5 y5 years-89.6%+515.9%-94.3%+676.9%
alltimeall time-89.6%+6163.4%-94.3%+2803.9%

Biohaven Pharmaceutical Holding Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$42.22 M(-1.1%)
June 2024
-
$42.69 M(+40.0%)
Mar 2024
-
$30.50 M(+2.3%)
Dec 2023
$29.81 M(-9.6%)
$29.81 M(-2.4%)
Sept 2023
-
$30.55 M(-3.4%)
June 2023
-
$31.63 M(-1.9%)
Mar 2023
-
$32.26 M(-2.2%)
Dec 2022
$32.99 M(+507.0%)
$32.99 M(+371.6%)
Sept 2022
-
$7.00 M(-5.1%)
June 2022
-
$7.37 M(+35.6%)
Dec 2021
$5.43 M(+12.3%)
-
Dec 2021
-
$5.43 M(-99.3%)
Dec 2020
$4.84 M(-98.3%)
-
Dec 2020
-
$741.56 M(+3.2%)
Sept 2020
-
$718.72 M(+145.0%)
June 2020
-
$293.30 M(+1.6%)
Mar 2020
-
$288.61 M
DateAnnualQuarterly
Dec 2019
$285.51 M(+138.8%)
-
Dec 2019
-
$285.51 M(+4.6%)
Sept 2019
-
$272.90 M(+5.2%)
June 2019
-
$259.50 M(+108.6%)
Mar 2019
-
$124.38 M(+4.0%)
Dec 2018
$119.56 M(+2078.5%)
-
Dec 2018
-
$119.56 M(+4.9%)
Sept 2018
-
$114.01 M(+5.9%)
June 2018
-
$107.70 M(+7307.5%)
Mar 2018
-
$1.45 M(-73.5%)
Dec 2017
$5.49 M(-91.4%)
-
Dec 2017
-
$5.49 M(-13.8%)
Sept 2017
-
$6.36 M(+63.9%)
June 2017
-
$3.88 M(-96.1%)
Mar 2017
-
$98.29 M(+53.3%)
Dec 2016
$64.11 M(>+9900.0%)
-
Dec 2016
-
$64.11 M
Dec 2015
$476.00 K
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual total long term liabilities year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly long term liabilities year-on-year change?

What is Biohaven Pharmaceutical Holding annual total long term liabilities?

The current annual total long term liabilities of BHVN is $29.81 M

What is the all time high annual total long term liabilities for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual total long term liabilities is $285.51 M

What is Biohaven Pharmaceutical Holding annual total long term liabilities year-on-year change?

Over the past year, BHVN annual total long term liabilities has changed by -$3.18 M (-9.63%)

What is Biohaven Pharmaceutical Holding quarterly total long term liabilities?

The current quarterly long term liabilities of BHVN is $42.22 M

What is the all time high quarterly long term liabilities for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly total long term liabilities is $741.56 M

What is Biohaven Pharmaceutical Holding quarterly long term liabilities year-on-year change?

Over the past year, BHVN quarterly total long term liabilities has changed by +$11.67 M (+38.20%)